Page last updated: 2024-08-22

gadolinium and Central Nervous System Diseases

gadolinium has been researched along with Central Nervous System Diseases in 40 studies

Research

Studies (40)

TimeframeStudies, this research(%)All Research%
pre-19904 (10.00)18.7374
1990's21 (52.50)18.2507
2000's8 (20.00)29.6817
2010's3 (7.50)24.3611
2020's4 (10.00)2.80

Authors

AuthorsStudies
Barkhof, F; Brouwer, I; Bø, L; Kerklingh, E; Lie, IA; Myhr, KM; Torkildsen, Ø; van Nederpelt, DR; Vrenken, H; Wesnes, K1
Aboye, AG; Balcha, TE; Woldeyohannes, AM1
Barnett, MH; Graham, SL; Klistorner, A; Klistorner, S; Parratt, J; Yiannikas, C1
Amoura, Z; Cohen Aubart, F; Galanaud, D; Haroche, J; Pineton de Chambrun, M1
Angstwurm, K; Bohner, G; Hofmann, J; Otto, C; Rothenfusser-Korber, E; Ruprecht, K; Scheibe, F; Vollrath, B; Wengert, O1
Butler, A; Guandalini, M; Mandelstam, S1
Brochet, B; Dousset, V; Petry, KG; Tourdias, T1
Hazama, Y; Ishibashi, M; Kimura, N; Kimura, Y; Kumamoto, T; Takahashi, Y1
Batocchi, AP; Caggiula, M; Colitto, F; Colosimo, C; Guzzetta, F; Lo Monaco, M; Mariotti, P; Tonali, PA1
Essig, M1
Banwell, B; Jeffery, D; Ness, JM; Schwid, S; Shroff, M; Weinstock-Guttman, B1
Lalwani, AK; Mallur, PS1
Akeson, P; Haugen, I; Holtås, S; Jonsson, E1
Nelson, KL; Runge, VM1
Kuijpers, TJ; Oudkerk, M; Sijens, PE; Van Beek, EJ1
Christensen, T; Lundorf, E; Svaland, MG1
Altman, NR; Ball, WS; Byrd, SE; Dietrich, RB; Drayer, BP; Morgan, FW; Nadel, SN; Nelson, MD; Prenger, EC; Zimmerman, RA1
Beck, W; Haustein, J; Kaiser, W; Laniado, M; Louton, T; Niendorf, HP; Planitzer, J; Reiser, M; Schöffel, M; Schörner, W1
Adams, D; Carlier, R; Doyon, D; Erdem, E; Idir, AB; Masnou, PO; Moulonguet, A1
Aisen, AM; Bradley, WG; Brant-Zawadzki, M; Dreisbach, JN; Haughton, VM; Kumar, AJ; Maravilla, KR; McNamara, MT; Sze, G; Weinreb, JC1
Atlas, SW1
Byrd, SE; Darling, CF; Wilczynski, MA1
Ekholm, S; Fagerlund, M; Holtås, S; Isberg, B; Jonsson, E; Lindell, D; Lindén, B; Sandvik, L; Sjöberg, S; Thuomas , KA; Tollesson, PO1
Gordon, P; Hugo, F; Lundby, B1
Colosimo, C; Manfredi, R; Tartaglione, T1
Kirchin, MA; Pirovano, GP; Spinazzi, A1
Baker, JF; Barr, R; Barr, W; Barron, B; Free, R; Gazelle, GS; Lambrecht, LJ; Maravilla, KR; Pierro, JA; Seltzer, S; Stevens, GR; Swan, SK; Tucker, RM1
Stevens, JM1
Brunberg, JA; Grodd, W; Grossman, RI; Haughton, VM; Heindel, W; Hunter, G; Jinkins, JR; Kanal, E; Kristy, RM; Kuhn, MJ; Lee, D; Leeds, N; Maravilla, K; Provenzale, JM; Ramsey, R; Rubin, DL; Simon, J; Stevens, GR; Sze, G; Truwit, C; Tu, R; Wippold, FJ; Zelch, J1
Cérez, D; Frédy, D; Méary, E; Meder, J; Zylberberg, F1
Jinkins, JR; Muroff, LR; Runge, VM1
Brant-Zawadzki, M1
Bradley, WG; Brant-Zawadzki, MN; Carvlin, MJ; Dean, BL; DeSimone, DN; Dillon, WP; Drayer, BP; Flanders, AE; Harms, SE; Runge, VM1
Gelblum, DY; Runge, VM1
Baierl, P; Bauer, WM; Fendel, H; Förster, C; Haustein, J; Mühlsteffen, A; Niendorf, HP1
Sze, G1
Carollo, BR; Gelblum, DY; Nelson, KL; Runge, VM; Wolf, CR1
Freeman, MW; Kessler, RM; Partain, CL; Powers, TA; Robertson, RH; Whelan, HT; Wyatt, SH1
Iio, M; Kono, T; Mano, I; Terao, H; Tsuchida, T; Yoshida, H1
Iio, M1

Reviews

12 review(s) available for gadolinium and Central Nervous System Diseases

ArticleYear
[A case of neurosarcoidosis with swelling and gadolinium enhancement of spinal nerve roots on magnetic resonance imaging].
    Rinsho shinkeigaku = Clinical neurology, 2011, Volume: 51, Issue:7

    Topics: Aged, 80 and over; Central Nervous System Diseases; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Sarcoidosis; Spinal Nerve Roots

2011
Clinical experience with MultiHance in CNS imaging.
    European radiology, 2003, Volume: 13 Suppl 3

    Topics: Central Nervous System Diseases; Contrast Media; Gadolinium; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Randomized Controlled Trials as Topic; Sensitivity and Specificity

2003
Basic principles of MR contrast.
    Topics in magnetic resonance imaging : TMRI, 1995,Summer, Volume: 7, Issue:3

    Topics: Central Nervous System Diseases; Contrast Media; Dextrans; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Organometallic Compounds; Oxides; Pentetic Acid

1995
Rationale and clinical indications for contrast agents in MR imaging of the brain and spine.
    Journal of computer assisted tomography, 1993, Volume: 17 Suppl 1

    Topics: Brain; Central Nervous System Diseases; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Reference Values; Sensitivity and Specificity; Spine

1993
Contrast enhancement issues in the MR evaluation of the central nervous system.
    European radiology, 1997, Volume: 7 Suppl 5

    Topics: Central Nervous System; Central Nervous System Diseases; Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Organometallic Compounds

1997
Gadobenate dimeglumine (Gd-BOPTA). An overview.
    Investigative radiology, 1998, Volume: 33, Issue:11

    Topics: Animals; Central Nervous System Diseases; Contrast Media; Gadolinium; Heart Diseases; Humans; Liver Diseases; Magnetic Resonance Angiography; Meglumine; Organometallic Compounds

1998
The spine and spinal cord.
    Current opinion in neurology and neurosurgery, 1990, Volume: 3, Issue:6

    Topics: Central Nervous System Diseases; Gadolinium; Humans; Magnetic Resonance Imaging; Myelography; Pentetic Acid; Spinal Cord Diseases; Spinal Diseases; Vascular Diseases

1990
[MRI aspects of central nervous system sarcoidosis].
    Journal de radiologie, 2001, Volume: 82, Issue:6 Pt 1

    Topics: Aftercare; Central Nervous System Diseases; Diagnosis, Differential; Gadolinium; Humans; Magnetic Resonance Imaging; Radioisotopes; Reproducibility of Results; Sarcoidosis; Sensitivity and Specificity; Treatment Outcome

2001
Central nervous system: review of clinical use of contrast media.
    Topics in magnetic resonance imaging : TMRI, 2001, Volume: 12, Issue:4

    Topics: Central Nervous System Diseases; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Organometallic Compounds

2001
Pitfalls of contrast-enhanced imaging in the nervous system.
    Magnetic resonance in medicine, 1991, Volume: 22, Issue:2

    Topics: Central Nervous System Diseases; Central Nervous System Neoplasms; Contrast Media; Costs and Cost Analysis; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid

1991
The role of gadolinium-diethylenetriaminepentaacetic acid in the evaluation of the central nervous system.
    Magnetic resonance quarterly, 1990, Volume: 6, Issue:2

    Topics: Central Nervous System; Central Nervous System Diseases; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Middle Aged; Organometallic Compounds; Pentetic Acid

1990
Gd DTPA: a review of clinical indications in central nervous system magnetic resonance imaging.
    Radiographics : a review publication of the Radiological Society of North America, Inc, 1989, Volume: 9, Issue:5

    Topics: Brain Neoplasms; Central Nervous System Diseases; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Prospective Studies; Spinal Diseases

1989

Trials

13 trial(s) available for gadolinium and Central Nervous System Diseases

ArticleYear
Contrast-enhanced MRI of the central nervous system: comparison between gadodiamide injection and gadolinium-DTPA.
    Neuroradiology, 1995, Volume: 37, Issue:3

    Topics: Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid

1995
Safety and efficacy of dotarem (Gd-DOTA) versus magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system.
    Investigative radiology, 1995, Volume: 30, Issue:2

    Topics: Adult; Aged; Central Nervous System; Central Nervous System Diseases; Chi-Square Distribution; Contrast Media; Double-Blind Method; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid

1995
Comparison of the safety of standard and triple dose gadodiamide injection in MR imaging of the central nervous system. A double-blind study.
    Acta radiologica (Stockholm, Sweden : 1987), 1994, Volume: 35, Issue:4

    Topics: Adult; Aged; Bilirubin; Blood Pressure; Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid; Safety; Spinal Cord Diseases

1994
Phase III multicenter clinical investigation to determine the safety and efficacy of gadoteridol in children suspected of having neurologic disease.
    Radiology, 1993, Volume: 186, Issue:3

    Topics: Adolescent; Brain; Central Nervous System Diseases; Child; Child, Preschool; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Infant; Magnetic Resonance Imaging; Male; Neurologic Examination; Organometallic Compounds; Spinal Cord

1993
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
    Radiology, 1993, Volume: 186, Issue:3

    Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid

1993
Use of the magnetic resonance contrast agent gadodiamide in the central nervous system. Results of a multicenter trial.
    Investigative radiology, 1993, Volume: 28 Suppl 1

    Topics: Central Nervous System Diseases; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid

1993
Magnetic resonance imaging of the central nervous system in children with a new nonionic gadolinium contrast agent--gadoteridol injection (ProHance).
    Journal of the National Medical Association, 1993, Volume: 85, Issue:5

    Topics: Adolescent; Central Nervous System; Central Nervous System Diseases; Child; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds

1993
Tolerance and efficacy of Omniscan (gadodiamide injection) in MR imaging of the central nervous system.
    Acta radiologica (Stockholm, Sweden : 1987), 1996, Volume: 37, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Central Nervous System Diseases; Contrast Media; Drug Tolerance; Female; Gadolinium; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid; Surveys and Questionnaires

1996
MRI in children given gadodiamide injection: safety and efficacy in CNS and body indications.
    European journal of radiology, 1996, Volume: 23, Issue:3

    Topics: Adolescent; Central Nervous System Diseases; Child; Child, Preschool; Clinical Trials, Phase III as Topic; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Infant; Infant, Newborn; Magnetic Resonance Imaging; Meglumine; Multicenter Studies as Topic; Organometallic Compounds; Pentetic Acid; Randomized Controlled Trials as Topic; Safety

1996
Pharmacokinetics, safety, and tolerability of gadoversetamide injection (OptiMARK) in subjects with central nervous system or liver pathology and varying degrees of renal function.
    Journal of magnetic resonance imaging : JMRI, 1999, Volume: 9, Issue:2

    Topics: Adult; Central Nervous System; Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium; Humans; Injections, Intravenous; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Renal Insufficiency; Safety

1999
Magnetic resonance imaging in patients with central nervous system pathology: a comparison of OptiMARK (Gd-DTPA-BMEA) and Magnevist (Gd-DTPA).
    Investigative radiology, 2000, Volume: 35, Issue:7

    Topics: Adult; Aged; Brain; Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium; Gadolinium DTPA; Humans; Male; Middle Aged; Organometallic Compounds; Spinal Cord

2000
Clinical safety and efficacy of gadoteridol: a study in 411 patients with suspected intracranial and spinal disease.
    Radiology, 1991, Volume: 181, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Brain; Central Nervous System Diseases; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Spinal Cord

1991
Central nervous system lesions in pediatric patients: Gd-DTPA-enhanced MR imaging.
    Radiology, 1988, Volume: 169, Issue:3

    Topics: Adolescent; Astrocytoma; Brain Neoplasms; Central Nervous System Diseases; Child; Child, Preschool; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma; Multicenter Studies as Topic; Organometallic Compounds; Pentetic Acid

1988

Other Studies

15 other study(ies) available for gadolinium and Central Nervous System Diseases

ArticleYear
The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis.
    European radiology, 2022, Volume: 32, Issue:5

    Topics: Atrophy; Brain; Central Nervous System Diseases; Contrast Media; Gadolinium; Gray Matter; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Neurodegenerative Diseases; Prospective Studies; Reproducibility of Results

2022
Imaging Findings of Concomitant Pulmonary and Central Nervous System Sarcoidosis: A Case Report.
    Ethiopian journal of health sciences, 2022, Volume: 32, Issue:3

    Topics: Brain; Central Nervous System Diseases; Contrast Media; Gadolinium; Humans; Lung; Male; Middle Aged; Sarcoidosis

2022
Choroid plexus volume in multiple sclerosis predicts expansion of chronic lesions and brain atrophy.
    Annals of clinical and translational neurology, 2022, Volume: 9, Issue:10

    Topics: Atrophy; Central Nervous System Diseases; Choroid Plexus; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Neurodegenerative Diseases

2022
The eclipse sign as a radiological presentation of neurosarcoidosis.
    The International journal of neuroscience, 2020, Volume: 130, Issue:5

    Topics: Adult; Brain; Central Nervous System Diseases; Female; Gadolinium; Granuloma; Humans; Magnetic Resonance Imaging; Male; Meninges; Middle Aged; Sarcoidosis

2020
Neurosarcoidosis: correlation of cerebrospinal fluid findings with diffuse leptomeningeal gadolinium enhancement on MRI and clinical disease activity.
    Journal of the neurological sciences, 2013, Dec-15, Volume: 335, Issue:1-2

    Topics: Adult; Aged; Central Nervous System Diseases; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Meninges; Middle Aged; PubMed; Retrospective Studies; Sarcoidosis; Statistics as Topic; Young Adult

2013
Spectrum of imaging appearances in Australian children with central nervous system hemophagocytic lymphohistiocytosis.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2014, Volume: 21, Issue:2

    Topics: Adolescent; Atrophy; Australia; Brain; Central Nervous System Diseases; Child; Child, Preschool; Diffusion Magnetic Resonance Imaging; Female; Gadolinium; Humans; Infant; Lymphohistiocytosis, Hemophagocytic; Magnetic Resonance Imaging; Male; Nerve Fibers, Myelinated; Optic Nerve; Retrospective Studies; Subdural Space; Treatment Outcome

2014
[Magnetic resonance imaging of central nervous system inflammation].
    Revue neurologique, 2009, Volume: 165 Suppl 3

    Topics: Animals; Central Nervous System Diseases; Gadolinium; Humans; Inflammation; Lysophosphatidylcholines; Magnetic Resonance Imaging; Rats; Sensitivity and Specificity

2009
Multiphasic demyelinating disease involving central and peripheral nervous system in a child.
    Neurology, 2003, Jan-28, Volume: 60, Issue:2

    Topics: Central Nervous System Diseases; Child; Demyelinating Diseases; Disease Progression; Encephalomyelitis, Acute Disseminated; Gadolinium; Humans; Immunoglobulins, Intravenous; Magnetic Resonance Imaging; Male; Peripheral Nervous System Diseases; Recurrence; Remission Induction

2003
MRI features of pediatric multiple sclerosis.
    Neurology, 2007, Apr-17, Volume: 68, Issue:16 Suppl 2

    Topics: Adult; Central Nervous System Diseases; Child; Contrast Media; Encephalomyelitis, Acute Disseminated; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Nerve Fibers, Myelinated; Pediatrics; Predictive Value of Tests; Prognosis

2007
Fluctuating corticosteroid-responsive auditory neuropathy/dyssynchrony is suggestive of central nervous system pathology.
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2007, Volume: 28, Issue:8

    Topics: Acyclovir; Adrenal Cortex Hormones; Antiviral Agents; Audiology; Audiometry, Pure-Tone; Central Nervous System Diseases; Child; Cochlear Nerve; Cyclophosphamide; Evoked Potentials, Auditory, Brain Stem; Female; Gadolinium; Hearing Loss, Unilateral; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Multiple Sclerosis; Myelin Sheath; Speech Discrimination Tests; Vestibulocochlear Nerve Diseases

2007
Gadolinium-enhanced MRI in central nervous system Behçet's disease.
    Neuroradiology, 1993, Volume: 35, Issue:2

    Topics: Adult; Behcet Syndrome; Brain; Central Nervous System Diseases; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Middle Aged; Tomography, X-Ray Computed

1993
Comparison of plain and Gd-DTPA-enhanced MR-imaging in children.
    Pediatric radiology, 1990, Volume: 20, Issue:7

    Topics: Adolescent; Brain Neoplasms; Central Nervous System Diseases; Child; Child, Preschool; Female; Gadolinium; Gadolinium DTPA; Humans; Infant; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Spinal Cord Neoplasms

1990
New applications of MR contrast agents in neuroradiology.
    Neuroradiology, 1990, Volume: 32, Issue:5

    Topics: Bone Diseases; Brain Neoplasms; Central Nervous System Diseases; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Meningeal Neoplasms; Meninges; Meningitis; Skull; Spinal Cord Diseases; Spinal Diseases

1990
[The enhancement effects of Gd-DTPA for cerebrospinal lesions-- comparison with conventional T2-weighted images].
    Rinsho hoshasen. Clinical radiography, 1987, Volume: 32, Issue:13

    Topics: Central Nervous System Diseases; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid

1987
[Contrast-enhanced MRI and contrast medium development].
    Nihon rinsho. Japanese journal of clinical medicine, 1987, Volume: 45, Issue:1

    Topics: Central Nervous System Diseases; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Spectroscopy; Organometallic Compounds; Pentetic Acid

1987